Natco Pharma Ltd.

BSE: 524816 | NSE: NATCOPHARM |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE987B01026 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Natco Pharma L Natco Pharma Ltd. | BSE 906.10 -12.85 (-1.40%) | NSE 905.65 -11.90 (-1.30%) | Trade | Add

BSE Live

Dec 12, 16:01

906.10 -12.85 (-1.40%)

Volume

AVERAGE VOLUME

5-Day

129,687

10-Day

196,325

30-Day

175,356

104,199

Prev. Close

918.95
Open Price

915.90

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Dec 12, 15:58

905.65 -11.90 (-1.30%)

Volume

AVERAGE VOLUME

5-Day

1,940,371

10-Day

3,002,982

30-Day

2,451,916

1,394,378

Prev. Close

917.55
Open Price

914.80

Bid Price (Qty.)
905.65 (5444)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Balance Sheet of Natco Pharma (in Rs. Cr.)	Mar 20	Mar 19	Mar 18	Mar 17	Mar 16
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	36.40	36.50	36.90	34.90	34.80
Total Share Capital	36.40	36.50	36.90	34.90	34.80
Reserves and Surplus	3,737.10	3,452.50	3,035.30	1,614.40	1,260.90
Total Reserves and Surplus	3,737.10	3,452.50	3,035.30	1,614.40	1,260.90
Total Shareholders Funds	3,773.50	3,489.00	3,072.20	1,649.30	1,295.70
Minority Interest	11.20	2.00	3.80	4.10	4.90
NON-CURRENT LIABILITIES
Long Term Borrowings	0.90	0.00	0.00	0.00	0.00
Deferred Tax Liabilities [Net]	25.90	11.60	13.90	15.00	14.70
Other Long Term Liabilities	0.80	0.80	0.80	0.80	0.80
Long Term Provisions	90.20	71.00	32.40	21.90	12.50
Total Non-Current Liabilities	117.80	83.40	47.10	37.70	28.00
CURRENT LIABILITIES
Short Term Borrowings	315.00	386.30	173.20	221.60	98.40
Trade Payables	255.40	217.00	269.10	262.70	275.60
Other Current Liabilities	104.40	116.40	136.00	140.40	117.60
Short Term Provisions	10.50	9.00	13.70	1.80	1.50
Total Current Liabilities	685.30	728.70	592.00	626.50	493.10
Total Capital And Liabilities	4,587.80	4,303.10	3,715.10	2,317.60	1,821.70
ASSETS
NON-CURRENT ASSETS
Tangible Assets	1,575.60	1,218.50	1,012.70	827.20	704.60
Intangible Assets	8.80	8.70	5.90	5.80	5.50
Capital Work-In-Progress	518.00	637.60	480.00	336.30	211.80
Fixed Assets	2,102.40	1,864.80	1,498.60	1,169.30	921.90
Non-Current Investments	83.60	19.90	8.10	0.10	0.10
Deferred Tax Assets [Net]	0.00	0.00	0.00	0.00	0.00
Long Term Loans And Advances	16.10	2.00	0.00	0.00	0.00
Other Non-Current Assets	60.10	69.20	77.70	60.90	62.70
Total Non-Current Assets	2,262.20	1,955.90	1,584.40	1,230.30	984.70
CURRENT ASSETS
Current Investments	28.70	148.70	68.40	32.10	22.10
Inventories	558.00	529.00	438.40	348.90	357.30
Trade Receivables	551.30	506.20	637.50	475.20	261.60
Cash And Cash Equivalents	66.00	279.50	183.70	35.80	45.20
Short Term Loans And Advances	8.40	7.10	4.50	3.50	2.80
OtherCurrentAssets	1,113.20	876.70	798.20	191.80	148.00
Total Current Assets	2,325.60	2,347.20	2,130.70	1,087.30	837.00
Total Assets	4,587.80	4,303.10	3,715.10	2,317.60	1,821.70
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	98.80	78.10	108.00	63.20	40.40
BONUS DETAILS
Bonus Equity Share Capital	5.73	5.74	5.81	5.81	5.81
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	51.20	0.00	0.00	0.00	0.00
Non-Current Investments Unquoted Book Value	33.50	19.90	8.10	0.10	0.10
CURRENT INVESTMENTS
Current Investments Quoted Market Value	5.00	6.80	8.30	9.00	2.10
Current Investments Unquoted Book Value	23.70	141.90	60.10	23.10	20.00